Expression and significance of Survivin and COX-2 in lung adenocarcinoma

TAN Ming-qi,ZHANG Xiu-juan,ZHOU Zhuo

2007-01-01

Abstract:[Objective] To study the expression of Survivin and its relationship with the expression of COX-2 in lung adenocarcinoma. [Methods] Expression of the Survivin and COX-2 proteins was evaluated by SP immunohistochemical methods in 38 lung adenocarcinoma samples and 16 benign pulmonary disease tissues. [Results] Positive rates were detected in a proportion of 55.3% for Survivin, 71.1% for COX-2 in lung adenocarcinoma respectively, in contrast to benign diseases, the differences were significant(P <0.01). The positive rate of Survivin in stage III+IV was higher than that of Survivin in stage I+II (P <0.05), but there was no relationship between Survivin expression and ages, gender, tumor sizes, tumor differentiation and lymphatic metastasis (P >0.05). There was no significant relationship between the expression of COX-2 and patients' clinicopathological features. Positive correlation was found between the expression of Survivin and COX-2 in lung adenocarcinoma. [Conclusion] The close relationships between the expression of Survivin and COX-2 indicate that they might play synergistic roles in the process of carcinogenesis of lung adenocarcinoma. Survivin and COX-2 may be identified as targets for target therapy of lung adenocarcinoma.